Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19
Clinical trial NCT05233826 · COMPLETED
Trial details
- NCT number
- NCT05233826
- Sponsor
- Codagenix, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2022-07-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.